Pluri Inc. Logo

Pluri Inc.

Biotechnology firm with 3D cell-expansion tech for manufacturing cell-based products.

PLUR | TA

Overview

Corporate Details

ISIN(s):
US72942G2030
LEI:
Country:
Israel
Address:
Park Building No. 5, 3508409 Haifa

Description

Pluri Inc. is a biotechnology company specializing in proprietary 3D cell-expansion technology. The company develops and operates platforms for the scalable, consistent, and cost-effective manufacturing of cell-based products. Its technology is applied across multiple sectors, including regenerative medicine, cell therapy, food technology, and agriculture technology (AgTech). Pluri aims to create next-generation cell-based products to improve human wellbeing and establishes partnerships to leverage its platform. The company also provides Contract Development and Manufacturing Organization (CDMO) services.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-22 15:07
Pluri and Remedy Cell Expand Collaboration; Successful Engineering Runs and Cli…
English 137.2 KB
2025-12-22 15:07
Pluri and Remedy Cell Expand Collaboration; Successful Engineering Runs and Cli…
English 36.4 KB
2025-12-10 00:23
Immediate Report
English 869.3 KB
2025-12-10 00:23
Immediate Report
English 36.5 KB
2025-12-09 16:31
Pluri Appoints Alejandro Weinstein as Chairman of the Board to Lead Strategic S…
English 130.5 KB
2025-12-09 16:31
Pluri Appoints Alejandro Weinstein as Chairman of the Board to Lead Strategic S…
English 36.4 KB
2025-12-09 00:29
Other Report or Announcement
English 283.7 KB
2025-12-09 00:29
Other Report or Announcement
English 36.5 KB
2025-12-09 00:26
Other Report or Announcement
English 163.6 KB
2025-12-09 00:26
Other Report or Announcement
English 36.5 KB
2025-12-09 00:25
Other Report or Announcement
English 165.1 KB
2025-12-09 00:25
Other Report or Announcement
English 36.4 KB
2025-12-09 00:23
Other Report or Announcement
English 163.4 KB
2025-12-09 00:23
Other Report or Announcement
English 36.4 KB
2025-12-09 00:22
Other Report or Announcement
English 163.7 KB

Automate Your Workflow. Get a real-time feed of all Pluri Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Pluri Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Pluri Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Biopharmaceutical firm developing cannabinoid-based medicines for inflammatory conditions.
United Kingdom
ANAN
Designs, develops, and manufactures molecular diagnostic solutions and instruments.
Türkiye
ANGEN
ANAVEX LIFE SCIENCES CORP. Logo
Clinical-stage biopharmaceutical company developing therapeutics for CNS disorders.
United States of America
AVXL
Anbio Biotechnology Logo
Develops and provides in-vitro diagnostic (IVD) solutions and instruments.
United States of America
NNNN
Anebulo Pharmaceuticals, Inc. Logo
Clinical-stage biotech developing therapies for acute cannabinoid intoxication.
United States of America
ANEB
AnGes, Inc. Logo
Biopharmaceutical firm developing gene-based and nucleotide-based medicines.
Japan
4563
Anika Therapeutics, Inc. Logo
A global joint preservation company developing solutions for orthopedic care.
United States of America
ANIK
ANIMALCARE GROUP PLC Logo
Develops and commercializes veterinary pharmaceutical products and services globally.
United Kingdom
ANCR
ANI PHARMACEUTICALS INC Logo
Develops, manufactures, and markets branded, generic, and OTC pharmaceutical products.
United States of America
ANIP
Annexin Pharmaceuticals AB Logo
Clinical-stage biotech developing a cell-protecting biologic for RVO and oncology.
Sweden
ANNX

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.